What are Evaxion A/S's key financial statements?

According to the latest financial statement (Form-10K), Evaxion A/S has a total asset of $0, Net loss of $0

What are the key financial ratios for EVAX?

Evaxion A/S's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Evaxion A/S's revenue broken down by segment or geography?

Evaxion A/S largest revenue segment is Artificial Intelligence-Immunology Powered Vaccines, at a revenue of 7,528,000 in the most earnings release.For geography, Denmark is the primary market for Evaxion A/S, at a revenue of 7,528,000.

Is Evaxion A/S profitable?

no, according to the latest financial statements, Evaxion A/S has a net loss of $0

Does Evaxion A/S have any liabilities?

no, Evaxion A/S has liability of 0

How many outstanding shares for Evaxion A/S?

Evaxion A/S has a total outstanding shares of 0

EVAX Financials: Evaxion A/S AI Analysis



Financials

EVAX Financial

Evaxion A/S

$2.96

-1.66%

$-0.04

As of today:Aug 31, 13:31:35 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$3.01

Open

$3.07

Day's Range

$2.91 - $3.07

52 week range

$2.52 - $12.14

Volume

66.3K

Avg.Volume

25.7K

Dividend yield

EPS (TTM)

-0.02

Market Cap

$24.6M

What is EVAX?

Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Features

Markets

News

Breakdown	TTM	06/30/2026	03/31/2026	12/31/2025	09/30/2025	06/30/2025
Revenue	7	0	0	0	7	0
Revenue Growth (YoY)	133%	--	--	--	133%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	5	1	1	1	1	2
Research & Development	10	2	2	2	3	2
Operating Expenses	13	3	3	4	4	4
Other Non Operating Income (Expenses)	--	--	0	0	--	--
Pretax Income	-9	-3	-3	-6	4	-5
Income Tax Expense	0	0	0	0	0	0
Net Income	-8	-3	-3	-5	4	-4
Net Income Growth	-27%	-25%	200%	67%	-500%	-33%
Shares Outstanding (Diluted)	417.01	417.01	417.01	412.24	318.04	315.82
Shares Change (YoY)	32%	32%	655%	3,402%	2,778%	2,836%
EPS (Diluted)	-0.01	0	0	-0.01	0.01	-0.01
EPS Growth	-42%	-42%	-70%	-95%	-109%	-97%
Free Cash Flow	-7	-8	--	1	--	-7
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-85.71%	0%	0%	0%	42.85%	0%
Profit Margin	-114.28%	0%	0%	0%	57.14%	0%
Free Cash Flow Margin	-100%	0%	--	0%	--	0%
EBITDA	-6	-3	--	-4	--	--
EBITDA Margin	-85.71%	0%	--	0%	--	--
D&A For EBITDA	0	0	--	0	--	--
EBIT	-6	-3	-3	-4	3	-4
EBIT Margin	-85.71%	0%	0%	0%	42.85%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Evaxion A/S (EVAX) Financial

EVAX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EVAX?

Evaxion A/S (EVAX) Financial

EVAX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is EVAX?

EVAX Income

Follow-Up Questions

What are Evaxion A/S's key financial statements?

What are the key financial ratios for EVAX?

How is Evaxion A/S's revenue broken down by segment or geography?

Is Evaxion A/S profitable?

Does Evaxion A/S have any liabilities?

How many outstanding shares for Evaxion A/S?